lorazepam has been researched along with ondansetron in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 16 (55.17) | 18.2507 |
| 2000's | 9 (31.03) | 29.6817 |
| 2010's | 3 (10.34) | 24.3611 |
| 2020's | 1 (3.45) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gill, A; Marsh, M; Roberts, JT; Sands, R | 1 |
| Ceuppens, PR; Hall, ST | 1 |
| Fredrikson, M; Fürst, CJ; Hursti, T; Johansson, S; Peterson, C; Steineck, G | 1 |
| O'Hanlon, JF; Swijgman, HF; Uiterwijk, MM; van Veggel, LM; Vermeeren, A | 1 |
| Mughal, TI | 1 |
| Autier, P; Bleiberg, H; Michaux, D | 1 |
| Fanning, J; Hilgers, RD | 1 |
| Ahn, MJ; Choi, SS; Kim, SH; Lee, JS; Lee, KH; Suh, C | 1 |
| Krstenansky, PM; Long, G; Petree, J | 1 |
| Baltzer, L; Kris, MG; Pisters, KM; Rigas, JR; Tyson, LB | 1 |
| Kilgore, JR; Navari, RM; Perrine, GM; Province, WS | 1 |
| Fox, JL; McGuire, TR; Narducci, WA | 1 |
| Bhattacharya, SK; Chakrabarti, A; Glover, V; Sandler, M | 1 |
| Crombez, R; Cunningham, D; de Mulder, P; Dicato, M; du Bois, A; McQuade, B; McRae, J; Parideans, R; Selby, P; Smyth, J; Stewart, A; van Straelen, D; Verweij, J | 1 |
| Busto, UE; Kaplan, HL; Romach, MK; Sellers, EM; Somer, G | 1 |
| Bearman, SI; Cagnoni, PJ; Day, TC; Jones, RB; Matthes, S; Shpall, EJ | 1 |
| Bonneterre, J; Harousseau, JL; Hedouin, M; Ouvry, J; Zittoun, R | 1 |
| Bilgrami, S; Bona, RD; Clive, J; Edwards, RL; Fox, J; Furlong, F; Li, Z; Naqvi, B; Shaikh, A; Tutschka, PJ | 1 |
| Chareoniam, V; Isariyodom, P; Manusirivithaya, S; Sungsab, D | 1 |
| Cartwright, J; Frangoul, H; Ho, RH; Jones, E; Koyama, T; Kuttesch, J; Shankar, S; Whitlock, JA | 1 |
| Kwon, P; Lefkowitz, W | 1 |
| Babu, K; Brantley, E; Cohn, J | 1 |
| Cheung, F; Doherty, SM; Tatara, AW | 1 |
3 review(s) available for lorazepam and ondansetron
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Cost-effectiveness analysis of antiemetic treatment.
Topics: Antiemetics; Cost-Benefit Analysis; Costs and Cost Analysis; Dexamethasone; Europe; European Union; Humans; Lorazepam; Metoclopramide; Ondansetron; Randomized Controlled Trials as Topic; Salvage Therapy; Serotonin Antagonists; Vomiting | 1994 |
Ketamine in Refractory Cyclic Vomiting Syndrome: A Case Report and Review of Literature.
Topics: Adult; Analgesics; Anesthetics; Humans; Hypnotics and Sedatives; Ketamine; Lorazepam; Male; Ondansetron; Receptors, N-Methyl-D-Aspartate; Vomiting | 2022 |
14 trial(s) available for lorazepam and ondansetron
| Article | Year |
|---|---|
A study to evaluate the effect of ondansetron on psychomotor performance after repeated oral dosing in healthy subjects.
Topics: Adult; Antipsychotic Agents; Double-Blind Method; Flicker Fusion; Humans; Imidazoles; Lorazepam; Male; Memory; Memory, Short-Term; Ondansetron; Psychomotor Performance; Reaction Time | 1991 |
Effects of ondansetron on chemotherapy-induced acute and delayed emesis--a pilot study.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Biperiden; Cisplatin; Dexamethasone; Doxorubicin; Drug Therapy, Combination; Female; Humans; Imidazoles; Lorazepam; Melphalan; Metoclopramide; Middle Aged; Ondansetron; Ovarian Neoplasms; Vomiting | 1991 |
Anxiolytics' effects on the actual driving performance of patients and healthy volunteers in a standardized test. An integration of three studies.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Attention; Automobile Driving; Cross-Over Studies; Diazepam; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Humans; Imidazoles; Lorazepam; Middle Aged; Naphthyridines; Ondansetron; Piperazines; Psychomotor Performance; Pyridines; Sulfur Compounds | 1995 |
Efficacy of Ondansetron and Lorazepam in controlling emesis associated with cytotoxic chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Middle Aged; Ondansetron; Vomiting | 1994 |
Ondansetron and metoclopramide fail to prevent vomiting secondary to ultra-high-dose cisplatin-carboplatin chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Dexamethasone; Diphenhydramine; Drug Therapy, Combination; Endometrial Neoplasms; Female; Humans; Lorazepam; Metoclopramide; Ondansetron; Ovarian Neoplasms; Prochlorperazine; Severity of Illness Index; Single-Blind Method; Treatment Failure; Vomiting | 1994 |
A randomized double-blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and lorazepam in the prevention of emesis due to cisplatin-based chemotherapy.
Topics: Adult; Aged; Cisplatin; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Lorazepam; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Prospective Studies; Treatment Outcome; Vomiting | 1994 |
The addition of ondansetron to the combination of metoclopramide, dexamethasone, and lorazepam did not improve vomiting prevention in patients receiving high-dose cisplatin.
Topics: Adult; Aged; Cisplatin; Dexamethasone; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Metoclopramide; Middle Aged; Ondansetron; Vomiting | 1994 |
Comparison of intermittent ondansetron versus continuous infusion metoclopramide used with standard combination antiemetics in control of acute nausea induced by cisplatin chemotherapy.
Topics: Adult; Aged; Antiemetics; Cisplatin; Costs and Cost Analysis; Dexamethasone; Diphenhydramine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Lorazepam; Male; Metoclopramide; Middle Aged; Nausea; Ondansetron | 1993 |
Optimum anti-emetic therapy for cisplatin induced emesis over repeat courses: ondansetron plus dexamethasone compared with metoclopramide, dexamethasone plus lorazepam.
Topics: Adult; Aged; Antiemetics; Cisplatin; Dexamethasone; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Europe; Female; Humans; Incidence; Lorazepam; Male; Metoclopramide; Middle Aged; Ondansetron | 1996 |
A controlled trial of ondansetron, a 5-HT3 antagonist, in benzodiazepine discontinuation.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety; Double-Blind Method; Female; Humans; Lorazepam; Male; Middle Aged; Ondansetron; Patient Compliance; Psychiatric Status Rating Scales; Substance Withdrawal Syndrome | 1998 |
Modification of the pharmacokinetics of high-dose cyclophosphamide and cisplatin by antiemetics.
Topics: Adult; Antiemetics; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Carmustine; Cisplatin; Cross-Linking Reagents; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lorazepam; Lung; Male; Middle Aged; Ondansetron; Prochlorperazine; Radiation-Sensitizing Agents; Retrospective Studies; Transplantation, Autologous | 1999 |
[Improvement in the control of chemotherapy induced emesis with ondansetron, methylprednisolone and lorazepam combination in patients treated by a moderate emetic treatment and uncontrolled by a previous antiemetic combination].
Topics: Adult; Antiemetics; Breast Neoplasms; Double-Blind Method; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Lorazepam; Male; Methylprednisolone; Middle Aged; Nausea; Ondansetron; Patient Satisfaction; Quality of Life; Vomiting | 2000 |
Dexamethasone, paclitaxel, etoposide, cyclophosphamide (d-TEC) and G-CSF for stem cell mobilisation in multiple myeloma.
Topics: Adult; Aged; Antiemetics; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Humans; Leukapheresis; Lorazepam; Male; Middle Aged; Multiple Myeloma; Ondansetron; Paclitaxel; Taxoids; Transplantation, Autologous | 2001 |
Comparison of ondansetron-dexamethasone-lorazepam versus metoclopramide-dexamethasone-lorazepam in the control of cisplatin induced emesis.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Chi-Square Distribution; Cisplatin; Dexamethasone; Drug Therapy, Combination; Female; Humans; Lorazepam; Metoclopramide; Middle Aged; Ondansetron; Ovarian Neoplasms; Treatment Outcome; Vomiting | 2001 |
12 other study(ies) available for lorazepam and ondansetron
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Low dose ondansetron and dexamethasone: a cost effective alternative to high dose metoclopramide/dexamethasone/lorazepam in the prevention of acute cisplatin induced emesis.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Cisplatin; Cost-Benefit Analysis; Dexamethasone; Female; Humans; Imidazoles; Lorazepam; Male; Metoclopramide; Middle Aged; Nausea; Ondansetron; Serotonin Antagonists; Vomiting | 1992 |
Extrapyramidal reaction caused by ondansetron.
Topics: Adult; Basal Ganglia Diseases; Humans; Leukemia, Myeloid, Acute; Lorazepam; Male; Ondansetron | 1994 |
Compatibility and stability of ondansetron hydrochloride, dexamethasone, and lorazepam in injectable solutions.
Topics: Dexamethasone; Drug Incompatibility; Drug Stability; Drug Storage; Humans; Injections; Lorazepam; Ondansetron | 1993 |
Rat brain monoamine oxidase A and B inhibitory (tribulin) activity during drug withdrawal anxiety.
Topics: Animals; Anxiety; Brain; Brain Chemistry; Cannabis; Ethanol; Isatin; Isoenzymes; Lorazepam; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Morphine; Nicotine; Ondansetron; Rats; Rats, Wistar; Substance Withdrawal Syndrome | 1995 |
Safety and efficacy of a continuous infusion, patient-controlled antiemetic pump for children receiving emetogenic chemotherapy.
Topics: Adolescent; Antiemetics; Antineoplastic Agents; Child; Child, Preschool; Confusion; Dexamethasone; Diphenhydramine; Drug Therapy, Combination; Female; Granisetron; Humans; Indoles; Infusion Pumps; Infusions, Intravenous; Length of Stay; Lorazepam; Male; Mood Disorders; Ondansetron; Patient Acceptance of Health Care; Quinolizines; Retrospective Studies; Self Administration; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Treatment Outcome; Vomiting | 2007 |
Neonatal extrapyramidal movements. Neonatal withdrawal due to maternal citalopram and ondansetron use.
Topics: Adult; Anti-Anxiety Agents; Basal Ganglia Diseases; Citalopram; Female; Humans; Infant, Newborn; Lorazepam; Maternal Welfare; Ondansetron; Phenobarbital; Pregnancy; Prenatal Exposure Delayed Effects; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome | 2008 |
Case files of the program in medical toxicology at brown university: amantadine withdrawal and the neuroleptic malignant syndrome.
Topics: Amantadine; Antipsychotic Agents; Diagnosis, Differential; Drug Therapy, Combination; Female; Fluid Therapy; Humans; Lorazepam; Middle Aged; Muscle Rigidity; Neuroleptic Malignant Syndrome; Ondansetron; Serotonin Syndrome; Substance Withdrawal Syndrome; Treatment Outcome | 2009 |